Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasciola hepatica | 26 | 2023 | 33 | 11.660 |
Why?
|
| Helminth Proteins | 13 | 2021 | 24 | 6.830 |
Why?
|
| Fascioliasis | 17 | 2020 | 18 | 4.780 |
Why?
|
| Fatty Acid-Binding Proteins | 6 | 2021 | 21 | 3.850 |
Why?
|
| Antigens, Helminth | 12 | 2018 | 33 | 3.690 |
Why?
|
| Antibodies, Helminth | 13 | 2018 | 22 | 3.140 |
Why?
|
| Macrophages | 6 | 2023 | 431 | 2.290 |
Why?
|
| Cytokines | 8 | 2023 | 569 | 2.140 |
Why?
|
| Saposins | 8 | 2018 | 10 | 2.010 |
Why?
|
| Lipopolysaccharides | 4 | 2023 | 200 | 1.860 |
Why?
|
| Shock, Septic | 3 | 2019 | 16 | 1.510 |
Why?
|
| Immunoglobulin G | 7 | 2024 | 232 | 1.470 |
Why?
|
| Antibodies, Neutralizing | 4 | 2024 | 102 | 1.370 |
Why?
|
| Glutathione Transferase | 3 | 2019 | 83 | 1.360 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2023 | 58 | 1.340 |
Why?
|
| Antibodies, Viral | 4 | 2024 | 252 | 1.150 |
Why?
|
| Vaccination | 7 | 2024 | 259 | 1.130 |
Why?
|
| Animals | 28 | 2023 | 14307 | 1.070 |
Why?
|
| Macrophages, Peritoneal | 2 | 2023 | 22 | 0.930 |
Why?
|
| Sepsis | 1 | 2023 | 76 | 0.890 |
Why?
|
| Mice | 14 | 2023 | 5668 | 0.830 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 445 | 0.820 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 23 | 0.820 |
Why?
|
| Mice, Inbred BALB C | 8 | 2021 | 649 | 0.790 |
Why?
|
| Dendritic Cells | 1 | 2021 | 112 | 0.790 |
Why?
|
| Monocytes | 2 | 2020 | 258 | 0.780 |
Why?
|
| Rabbits | 8 | 2018 | 278 | 0.750 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 47 | 0.720 |
Why?
|
| Inclusion Bodies | 2 | 2018 | 33 | 0.720 |
Why?
|
| Vaccines, Synthetic | 3 | 2010 | 72 | 0.700 |
Why?
|
| Schistosoma mansoni | 2 | 2011 | 20 | 0.690 |
Why?
|
| Protein Engineering | 1 | 2018 | 40 | 0.650 |
Why?
|
| Serologic Tests | 6 | 2022 | 43 | 0.580 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 112 | 0.580 |
Why?
|
| NF-kappa B | 1 | 2019 | 306 | 0.570 |
Why?
|
| Humans | 24 | 2024 | 34853 | 0.560 |
Why?
|
| RNA, Messenger | 4 | 2024 | 1152 | 0.560 |
Why?
|
| Cell Movement | 1 | 2018 | 545 | 0.530 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 75 | 0.520 |
Why?
|
| Macrophage Activation | 1 | 2014 | 52 | 0.500 |
Why?
|
| Apoptosis | 1 | 2021 | 1317 | 0.490 |
Why?
|
| Proteomics | 2 | 2020 | 302 | 0.490 |
Why?
|
| Parasitology | 1 | 2013 | 2 | 0.490 |
Why?
|
| Escherichia coli | 4 | 2023 | 436 | 0.490 |
Why?
|
| Recombinant Proteins | 5 | 2018 | 485 | 0.480 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 555 | 0.470 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 47 | 0.430 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 22 | 0.410 |
Why?
|
| Ferritins | 1 | 2011 | 54 | 0.400 |
Why?
|
| Tremor | 1 | 2011 | 7 | 0.400 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 1300 | 0.400 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 24 | 0.400 |
Why?
|
| Movement | 1 | 2011 | 86 | 0.390 |
Why?
|
| Female | 12 | 2023 | 19873 | 0.380 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 126 | 0.380 |
Why?
|
| Signal Transduction | 1 | 2019 | 1802 | 0.370 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 600 | 0.360 |
Why?
|
| Proteome | 1 | 2011 | 132 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 283 | 0.360 |
Why?
|
| Puerto Rico | 3 | 2023 | 1352 | 0.340 |
Why?
|
| DNA, Complementary | 4 | 2011 | 175 | 0.340 |
Why?
|
| Epitope Mapping | 2 | 2016 | 31 | 0.330 |
Why?
|
| Isoelectric Focusing | 2 | 2020 | 16 | 0.320 |
Why?
|
| Cloning, Molecular | 3 | 2017 | 310 | 0.300 |
Why?
|
| Spleen | 3 | 2018 | 192 | 0.300 |
Why?
|
| Glycoproteins | 2 | 2004 | 100 | 0.300 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2006 | 10 | 0.290 |
Why?
|
| Epitopes | 1 | 2007 | 145 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 968 | 0.290 |
Why?
|
| Mice, Knockout | 2 | 2021 | 897 | 0.270 |
Why?
|
| Vaccines, DNA | 1 | 2005 | 23 | 0.270 |
Why?
|
| Chromatography, Affinity | 2 | 2018 | 64 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1530 | 0.260 |
Why?
|
| Flow Cytometry | 2 | 2021 | 392 | 0.260 |
Why?
|
| Blotting, Western | 4 | 2016 | 834 | 0.260 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 1124 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2015 | 91 | 0.250 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2023 | 38 | 0.240 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1442 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 224 | 0.220 |
Why?
|
| Neutralization Tests | 1 | 2021 | 53 | 0.210 |
Why?
|
| Cross Reactions | 3 | 2016 | 83 | 0.210 |
Why?
|
| Molecular Weight | 2 | 2012 | 161 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 248 | 0.190 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1490 | 0.190 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2020 | 25 | 0.190 |
Why?
|
| Placenta | 1 | 2020 | 91 | 0.180 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 316 | 0.180 |
Why?
|
| Gene Expression | 2 | 2017 | 639 | 0.180 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 58 | 0.170 |
Why?
|
| Cytosol | 1 | 2018 | 85 | 0.170 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 964 | 0.170 |
Why?
|
| Cell-Free System | 1 | 2018 | 15 | 0.170 |
Why?
|
| Protein Binding | 1 | 2021 | 913 | 0.170 |
Why?
|
| Cell Survival | 1 | 2021 | 818 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2018 | 73 | 0.170 |
Why?
|
| Fatty Acids | 1 | 2018 | 118 | 0.160 |
Why?
|
| Parasite Egg Count | 2 | 2009 | 4 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 406 | 0.160 |
Why?
|
| Sequence Alignment | 2 | 2011 | 257 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 197 | 0.150 |
Why?
|
| DNA, Helminth | 2 | 2010 | 5 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 66 | 0.150 |
Why?
|
| Mutation | 1 | 2021 | 1023 | 0.150 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2016 | 1 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 286 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 383 | 0.140 |
Why?
|
| Immunoglobulin E | 2 | 2007 | 54 | 0.140 |
Why?
|
| Cell Line | 1 | 2020 | 1289 | 0.140 |
Why?
|
| Inflammation | 2 | 2023 | 577 | 0.140 |
Why?
|
| Antigens, Protozoan | 1 | 2016 | 71 | 0.140 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 68 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 325 | 0.130 |
Why?
|
| Chagas Disease | 1 | 2016 | 96 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 106 | 0.130 |
Why?
|
| Survival Rate | 1 | 2015 | 310 | 0.130 |
Why?
|
| Chromatography, Gel | 1 | 2014 | 46 | 0.130 |
Why?
|
| Immune Evasion | 1 | 2014 | 16 | 0.130 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 144 | 0.130 |
Why?
|
| Liver | 2 | 2009 | 447 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 90 | 0.130 |
Why?
|
| Integumentary System | 1 | 2013 | 1 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2017 | 751 | 0.120 |
Why?
|
| Male | 4 | 2021 | 18870 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 59 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 210 | 0.110 |
Why?
|
| Adult | 2 | 2021 | 11034 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 240 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2014 | 420 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2016 | 469 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2014 | 287 | 0.110 |
Why?
|
| Immunologic Tests | 1 | 2011 | 11 | 0.110 |
Why?
|
| Gene Library | 1 | 2012 | 55 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2015 | 878 | 0.110 |
Why?
|
| Isoelectric Point | 1 | 2011 | 9 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 172 | 0.100 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 79 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 100 | 0.100 |
Why?
|
| DNA, Recombinant | 1 | 2010 | 16 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2013 | 366 | 0.090 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 20 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 34 | 0.090 |
Why?
|
| Iron | 1 | 2011 | 204 | 0.090 |
Why?
|
| Aged | 1 | 2021 | 6448 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 164 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 472 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 859 | 0.090 |
Why?
|
| DNA Primers | 1 | 2009 | 269 | 0.090 |
Why?
|
| Plasmids | 1 | 2010 | 233 | 0.090 |
Why?
|
| Phylogeny | 1 | 2011 | 612 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.080 |
Why?
|
| Middle Aged | 1 | 2021 | 9642 | 0.080 |
Why?
|
| Schistosomiasis mansoni | 1 | 2006 | 11 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 901 | 0.070 |
Why?
|
| Peptide Library | 1 | 2006 | 25 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 222 | 0.070 |
Why?
|
| Bile | 1 | 2004 | 10 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 105 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 341 | 0.060 |
Why?
|
| Feces | 1 | 2004 | 110 | 0.060 |
Why?
|
| Sphingolipid Activator Proteins | 1 | 2003 | 1 | 0.060 |
Why?
|
| Proteolipids | 1 | 2003 | 3 | 0.060 |
Why?
|
| RNA, Helminth | 1 | 2003 | 4 | 0.060 |
Why?
|
| Vagina | 1 | 2023 | 81 | 0.060 |
Why?
|
| Immune Sera | 1 | 2003 | 59 | 0.060 |
Why?
|
| Peptides | 1 | 2006 | 308 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2003 | 139 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 165 | 0.060 |
Why?
|
| Pulmonary Surfactants | 1 | 2003 | 26 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 249 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 528 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2003 | 107 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 21 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 67 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 99 | 0.040 |
Why?
|
| Hookworm Infections | 1 | 2016 | 1 | 0.040 |
Why?
|
| Schistosomiasis japonica | 1 | 2016 | 1 | 0.040 |
Why?
|
| Toxocariasis | 1 | 2016 | 2 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 185 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 81 | 0.040 |
Why?
|
| Multigene Family | 1 | 2016 | 105 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2016 | 77 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1503 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1056 | 0.030 |
Why?
|